CA1087094A - Gastric acid neutralizing antacid agent - Google Patents
Gastric acid neutralizing antacid agentInfo
- Publication number
- CA1087094A CA1087094A CA279,734A CA279734A CA1087094A CA 1087094 A CA1087094 A CA 1087094A CA 279734 A CA279734 A CA 279734A CA 1087094 A CA1087094 A CA 1087094A
- Authority
- CA
- Canada
- Prior art keywords
- acid
- polyethyleneimine
- weight
- aqueous solution
- gastric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Control Of Combustion (AREA)
- Manufacturing Of Printed Circuit Boards (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE7606256-1 | 1976-06-03 | ||
| SE7606256A SE405445B (sv) | 1976-06-03 | 1976-06-03 | Forfarande for framstellning av ett magsyreneutraliserande antacidum i flytande form innehallande polyetylenimin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1087094A true CA1087094A (en) | 1980-10-07 |
Family
ID=20328121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA279,734A Expired CA1087094A (en) | 1976-06-03 | 1977-06-02 | Gastric acid neutralizing antacid agent |
Country Status (21)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5936192B2 (ja) * | 2012-10-25 | 2016-06-15 | 学校法人神奈川大学 | キラル超分子結晶及びそれからなる固体触媒、並びにキラル超分子結晶の製造方法 |
-
1976
- 1976-06-03 SE SE7606256A patent/SE405445B/xx unknown
-
1977
- 1977-05-16 ZA ZA00772913A patent/ZA772913B/xx unknown
- 1977-05-18 DE DE19772722486 patent/DE2722486A1/de not_active Withdrawn
- 1977-05-24 FI FI771660A patent/FI59023C/fi not_active IP Right Cessation
- 1977-05-27 DK DK234077A patent/DK234077A/da unknown
- 1977-05-30 NZ NZ184237A patent/NZ184237A/xx unknown
- 1977-05-30 AU AU25612/77A patent/AU514929B2/en not_active Expired
- 1977-05-31 NO NO771899A patent/NO771899L/no unknown
- 1977-05-31 IE IE1120/77A patent/IE45208B1/en unknown
- 1977-06-01 CS CS773612A patent/CS207459B2/cs unknown
- 1977-06-01 DD DD7700199241A patent/DD131345A5/xx unknown
- 1977-06-01 HU HU77HE737A patent/HU174584B/hu unknown
- 1977-06-02 FR FR7716916A patent/FR2353296A1/fr active Granted
- 1977-06-02 SU SU772490602A patent/SU812156A3/ru active
- 1977-06-02 CA CA279,734A patent/CA1087094A/en not_active Expired
- 1977-06-02 NL NL7706085A patent/NL7706085A/xx not_active Application Discontinuation
- 1977-06-02 GB GB23486/77A patent/GB1539162A/en not_active Expired
- 1977-06-03 LU LU77480A patent/LU77480A1/xx unknown
- 1977-06-03 BE BE178155A patent/BE855349A/xx unknown
- 1977-06-03 AT AT393877A patent/AT353406B/de not_active IP Right Cessation
- 1977-06-03 JP JP6568177A patent/JPS52148630A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| FR2353296B1 (US20110009641A1-20110113-C00116.png) | 1981-01-16 |
| HU174584B (hu) | 1980-02-28 |
| ZA772913B (en) | 1978-04-26 |
| IE45208L (en) | 1977-12-03 |
| AU514929B2 (en) | 1981-03-05 |
| FI59023B (fi) | 1981-02-27 |
| CS207459B2 (en) | 1981-07-31 |
| LU77480A1 (US20110009641A1-20110113-C00116.png) | 1978-01-26 |
| DD131345A5 (de) | 1978-06-21 |
| FI771660A (US20110009641A1-20110113-C00116.png) | 1977-12-04 |
| SE7606256L (sv) | 1977-12-04 |
| AU2561277A (en) | 1978-12-07 |
| SE405445B (sv) | 1978-12-11 |
| IE45208B1 (en) | 1982-07-14 |
| GB1539162A (en) | 1979-01-31 |
| AT353406B (de) | 1979-11-12 |
| FI59023C (fi) | 1981-06-10 |
| DE2722486A1 (de) | 1977-12-22 |
| JPS52148630A (en) | 1977-12-10 |
| BE855349A (fr) | 1977-12-05 |
| NZ184237A (en) | 1979-10-25 |
| NL7706085A (nl) | 1977-12-06 |
| FR2353296A1 (fr) | 1977-12-30 |
| SU812156A3 (ru) | 1981-03-07 |
| DK234077A (da) | 1977-12-04 |
| NO771899L (no) | 1977-12-06 |
| ATA393877A (de) | 1979-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220241189A1 (en) | Modified release drug powder composition comprising gastro-retentive raft forming systems having trigger pulse drug release | |
| US7094429B2 (en) | Process for preparing tannate liquid and semi-solid dosage forms | |
| JPH0434966B2 (US20110009641A1-20110113-C00116.png) | ||
| JPH0324020A (ja) | スクラルフエートおよび薬剤ならびにその調製方法 | |
| US4704278A (en) | Fluidized magaldrate suspension | |
| CA1087094A (en) | Gastric acid neutralizing antacid agent | |
| US3248290A (en) | Antitussive compositions | |
| US3794722A (en) | Iron composition for treating anemia | |
| JPH10501235A (ja) | 速溶解性剤形 | |
| GB1582737A (en) | Concentrated magnesium hydroxide suspensions or emulsions and method for production thereof | |
| AU2011255951C1 (en) | Pharmaceutical composition containing solifenacin | |
| US4191744A (en) | Neutralizing agent | |
| JPH09502709A (ja) | エストロン誘導体及びカルシウム塩含有の経口、水溶性製薬組成物 | |
| WO1995025513A1 (en) | Zinc compound and cyclodextrine for treatment of gastric disorders | |
| EP1188441A1 (en) | Oral preparations of etidronate disodium | |
| NZ337864A (en) | Heat stable antacid and antigas suspensions containing hydroxyethylcellulose (HEC) for aid in pasteurisation process | |
| US2294889A (en) | Medicinal product | |
| KR890000208B1 (ko) | 마갈드레이트 조성물의 제조방법 | |
| WO2006100527A1 (en) | Effervescent tablet containing sodium alendronate and related use and process | |
| CA1252045A (en) | Fluidized magaldrate suspension | |
| EP0715520B1 (en) | Use of a suspension based on sucralphate gel as antacid | |
| CA1283854C (en) | Exogenously acidified antacid compositions having cytoprotective properties | |
| WO2013010210A1 (en) | Oral compositions comprising an antacid, an anaesthetic and an inorganic matrix comprising silicon dioxide and titanium dioxide | |
| AU2004201831B2 (en) | Heat stable antacid and antigas suspensions | |
| IE893167A1 (en) | Preparation of orally administrable liquids for use in¹therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |